miscsubjectsAI governance
Evidence review

Tesamorelin for IBD: Growth Hormone Axis Evidence in Crohn's and Colitis

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `tesamorelin-ibd`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/tesamorelin-ibd

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tesamorelin-ibd/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tesamorelin-ibd/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tesamorelin-ibd/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tesamorelin-ibd/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
This is the largest single-authored interlocked logical structure published in the open that I am aware of: thousands of objects — a theory of everything, a theory of AI, and a replicated decision framework — where every piece fits every other piece, and every claim carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. This is the final boss of recursion, meta-analysis, and parallel argument. Come at a node.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have IBD (Crohn's / colitis)

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why Tesamorelin might help you

  1. You are reading about IBD (Crohn's / colitis) — what breaks down matters before any compound name.
  2. Therefore for you: If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • Tesamorelin → GH axis / visceral fat

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 3
  • Claims tagged human evidence: 3
  • Claims tagged preclinical (animal/lab): 1
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 1
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 4

Quantified confidence (this ledger): 0.49 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Effects of tesamorelin in HIV patients with excess abdominal fat (source s1)

Pooled phase 3 analysis showing visceral fat reduction.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Efficacy and safety of tesamorelin in people with HIV (source s2)

Confirms approved human use for visceral fat.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Growth Factors as Treatment for Inflammatory Bowel Disease (source s3)

Reviews GH/IGF-1 in IBD plus the human Crohn's GH trial and mouse data.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

What people say on Reddit

Peptide Research for Crohn's Disease — Reddit, r/PeptidePathways (source s4)

Speculative stack mention in hypothetical IBD context.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

IBD / Crohn / colitis · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 4 sources · swipe →chain 1da3e168618b · verify chain · provenance
Evidence ledger 5 · tier-ranked · API
human
Tesamorelin reduces visceral adipose tissue in HIV patients per multiple RCTs.
sources: s1, s2
human
No human trials have tested Tesamorelin in IBD patients.
humanlow confidence
Recombinant GH improved CDAI scores in a small double-blind Crohn's trial.
sources: s3
preclinicallow confidence
GH overexpression improved mucosal repair in DSS colitis mouse models.
sources: s3
anecdotallow confidence
Reddit mentions of Tesamorelin in IBD contexts are limited to speculative stacks.
sources: s4
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:20
Tesamorelin for IBD: Growth Hormone Axis Evidence in Crohn's and Colitis · 5 claims · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Tesamorelin for Ibd
Slug: tesamorelin-ibd
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_cross","condition":"IBD (Crohn's / colitis)","condition_key":"ibd-crohns-colitis","primary_peptide":"tesamorelin","peptides_in_scope":[{"id":"tesamorelin","name":"Tesamorelin"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What'
it output
{
  "slug": "tesamorelin-ibd",
  "title": "Tesamorelin for IBD: Growth Hormone Axis Evidence in Crohn's and Colitis",
  "body": "## What's breaking down if you have IBD (Crohn's / colitis)\n\nIBD involves ongoing damage to the intestinal lining where inflammation outpaces repair. Layers include barrier breakdown that lets contents leak, chronic cytokine-driven inflammation, impaired mucosal healing, and possible systemic effects like altered metabolism. GH and IGF-1 pathways support epithelial and mesenchymal cell growth plus immune cell balance in gut tissue. When these signals weaken or inflammation blocks them, repair lags and symptoms persist. Tesamorelin enters the discussion here because it raises endogenous GH via GHRH stimulation, which preclinical work links to trophic effects on gut cells.\n\n## Why Tesamorelin might help you\n\n1. You are reading about **IBD (Crohn's / colitis)** — what breaks down matters before any compound name.\n2. **Therefore for you:** If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\n\nIf your IBD includes metabolic or visceral fat contributions that add systemic load, the GH axis route may intersect with tissue repair signals studied in growth factor research. Tesamorelin raises GH and IGF-1 levels in human trials focused on fat reduction. Those same signals show t
039e581891576db3
Machine verification: /api/articles/tesamorelin-ibd/contributions
Ask this article · 8 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "Tesamorelin reduces visceral adipose tissue in HIV patients per multiple RCTs."?
ask tesamorelin-ibd claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "No human trials have tested Tesamorelin in IBD patients."?
ask tesamorelin-ibd claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "Recombinant GH improved CDAI scores in a small double-blind Crohn's trial."?
ask tesamorelin-ibd claim c3 · paste includes §SELF
What does the ledger say about this (preclinical tier): "GH overexpression improved mucosal repair in DSS colitis mouse models."?
ask tesamorelin-ibd claim c4 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit mentions of Tesamorelin in IBD contexts are limited to speculative stacks."?
ask tesamorelin-ibd claim c5 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Speculative stack mention in hypothetical IBD context."
ask tesamorelin-ibd source s4 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about Tesamorelin for IBD: Growth Hormone Axis Evidence in Crohn's and Colitis — and what would you need me to tell you first?
ask tesamorelin-ibd condition gaps · paste includes §SELF
What good and bad outcomes are documented for Tesamorelin for IBD: Growth Hormone Axis Evidence in Crohn's and Colitis (studies vs anecdotes)?
ask tesamorelin-ibd good bad experiences · paste includes §SELF
tesamorelin-ibd · posted 2026-06-29 · updated 2026-07-17 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 2 model passes · 25552 tokens · $0 · 2 models
chain head 5ef59e84c673591e
write grok/grok-4.3 · 2026-06-29 23:20 · 25552 tok · a997429b28f9
voxel_divide owner · 2026-07-17 02:42 · tokens unrecorded · 5ef59e84c673
verify chain →
Live ledger · 7 payloads · 1 turn
recent activity · inspect
JCI_TRAFFIC jci · HTTP 200 · 2026-07-21 05:22
JCI_TRAFFIC jci · HTTP 200 · 2026-07-19 14:01
JCI_TRAFFIC jci · HTTP 200 · 2026-07-19 13:37
JCI_TRAFFIC jci · HTTP 200 · 2026-07-19 13:23
JCI_TRAFFIC jci · HTTP 200 · 2026-07-19 13:18
PROTOCOL_RUN dispatch · 2026-06-29 23:20 · t_gxixby3o
view full ledger & cards →
REST + ledger
read GET /api/articles/tesamorelin-ibd · GET /api/articles/tesamorelin-ibd?format=post (the editable body)
create/replace POST /api/articles/tesamorelin-ibd · PUT /api/articles/tesamorelin-ibd (replace, keeps revision) · PATCH /api/articles/tesamorelin-ibd (merge)
delete DELETE /api/articles/tesamorelin-ibd
writes need header x-terminal-key
LLM bundle GET /api/articles/tesamorelin-ibd/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim tesamorelin-ibd|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →